AusCann Competitors

Delisted . USA . 
Stock . AusCann Group Holdings
ACNNFDelisted Stock  USD 0  0.0007  22.58%   
AusCann Group Holdings competes with Crescita Therapeutics; as well as few others. The company classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Analyzing AusCann Group competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of AusCann Group to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of AusCann Group competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.00050.19
Details
Intrinsic
Valuation
LowRealHigh
0.00050.19
Details
Naive
Forecast
LowNextHigh
0.00010.0181.33
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details

AusCann Group Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between AusCann Group and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of AusCann and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of AusCann Group Holdings does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
CRRTF
+ 0.7
ATHJF
CRRTF
+ 0.35
ANTCF
CRRTF
+ 0.28
BCBCF
ATHJF
+ 0.16
ANTCF
ANTCF
+ 0.0
AXRX
APNHF
+ 0.0
AXRX
  
High negative correlations   
ABTI
- 0.21
ATHJF
BCBCF
- 0.19
ABTI
CRRTF
- 0.16
ABTI
BCBCF
- 0.07
ATHJF
ABTI
- 0.07
ANTCF
BCBCF
- 0.05
ANTCF

Risk-Adjusted Indicators

There is a big difference between AusCann Pink Sheet performing well and AusCann Group Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze AusCann Group's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

AusCann Group Competitive Analysis

The better you understand AusCann Group competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, AusCann Group's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across AusCann Group's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ACNNF AXRX ANTCF APNHF ATHJF ABTI BCBCF CRRTF
 22.58 
 0 
AusCann
 0.00 
 0 
Amexdrug
 185.71 
 0.03 
Aion
 0.00 
 12.25 
Aspen
 0.00 
 0.04 
Antisense
 25.00 
 0.01 
Alterola
 0.00 
 0.05 
BCBCF
 0.00 
 0.45 
Crescita
Market Volatility
(90 Days Market Risk)
Out of control
Very steady
Out of control
Very steady
Out of control
Out of control
Out of control
Out of control
Market Performance
(90 Days Performance)
Solid
Very Weak
Good
Very Weak
OK
Modest
Good
OK
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
Quite High
Dangerous
Below Average
Average
Low
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Cautious Hold
Not Rated
Hold
Strong Sell
Cautious Hold
Strong Sell
Current Ratio
23.92 X
1.35 X
0.15 X
1.96 X
19.14 X
0.10 X
6.38 X
3.10 X
Net Asset
18.45 M
2.31 M
150.14 K
111.38 B
22.44 M
12.13 K
1.95 M
28.92 M
Profit Margin
N/A
0.02 %
N/A
0.17 %
N/A
N/A
(1.96) %
0.03 %
EBITDA
(5.07 M)
380.83 K
(3.68 M)
10.61 B
(7.52 M)
(6.47 M)
(2.83 M)
606 K
Operating Margin
(2.40) %
0.04 %
N/A
0.23 %
(3.28) %
N/A
(1.82) %
0.04 %
Current Valuation
(2.97 M)
34.51 M
1.22 M
4.58 B
27.82 M
68.08 M
1.82 M
3.64 M
Price To Book
0.07 X
51.38 X
5.77 X
0.98 X
3.05 X
6.29 X
3.14 X
0.66 X
Retained Earnings
N/A
961 K
N/A
28.4 B
(53 M)
N/A
N/A
N/A
Current Asset
N/A
1.76 M
N/A
37.2 B
5 M
N/A
N/A
N/A
Beta
0.96
-0.72
0.29
0.62
0.67
-6.65
N/A
2.08
Number Of Employees
14
9
4
8.58 K
12
6
4
2
Shares Outstanding
440.55 M
169.11 M
147.3 M
444.95 M
669.04 M
807.05 M
53.02 M
20.4 M
Cash Flow From Operations
(2.83 M)
27.49 K
(1.35 M)
5.37 B
(7.81 M)
44.34 K
(875.7 K)
(1.6 M)
Annual Yield
N/A
N/A
N/A
0.02 %
N/A
N/A
N/A
N/A
Total Debt
39.87 K
961.12 K
643.8 K
105 M
227.4 K
251.18 K
94.47 K
1.71 M
Return On Equity
-0.8
0.29
-4.17
0.095
-0.43
-1.27
-0.32
0.0318
Z Score
N/A
14.2
-78.0
22.2
N/A
N/A
21.9
3.6
Return On Asset
-0.0964
0.11
-0.96
0.0499
-0.25
-0.67
-0.18
0.0227
Book Value Per Share
0.04 X
0 X
(0.01) X
159.44 X
0.03 X
0.01 X
0.02 X
0.97 X
Current Liabilities
N/A
798 K
N/A
21.1 B
1000 K
N/A
N/A
N/A
Total Asset
18.45 M
2.31 M
150.14 K
111.38 B
22.44 M
12.13 K
1.95 M
28.92 M
Debt To Equity
0 %
1.46 %
0.14 %
0.38 %
0.01 %
0.02 %
0.07 %
0.09 %
Last Dividend Paid
N/A
N/A
N/A
3.26
N/A
N/A
N/A
N/A
Shares Owned By Institutions
16.42 %
N/A
N/A
60.77 %
4.93 %
N/A
N/A
N/A
Market Capitalization
11.83 M
16.91 M
1.47 M
3.92 B
41.78 M
39.55 M
4.03 M
11.42 M
Price To Earning
(53.62) X
165.00 X
N/A
11.83 X
(3.62) X
N/A
N/A
490.00 X
Price To Sales
7.99 X
3.04 X
N/A
0.10 X
24.46 X
N/A
4.63 X
0.41 X
Net Income
(26.36 M)
111.36 K
(3.82 M)
6.49 B
(5.81 M)
(6.47 M)
(2.86 M)
(1.1 M)
Earnings Per Share
(0.01) X
N/A
(0.04) X
0.80 X
(0.01) X
(0.01) X
N/A
0.02 X
Shares Owned By Insiders
12.71 %
N/A
17.68 %
19.32 %
19.30 %
N/A
66.39 %
7.30 %
Revenue
29.73 K
10.43 M
N/A
38.61 B
1.78 M
N/A
151
16.77 M
Working Capital
N/A
966 K
N/A
16.1 B
4 M
N/A
N/A
N/A
Cash And Equivalents
5.76 M
168.01 K
1.85 K
7.88 B
19.23 M
61.54 K
740.29 K
10.5 M
Cash Per Share
0.01 X
N/A
N/A
17.25 X
0.03 X
N/A
0.02 X
0.51 X
Gross Profit
336.67 K
1.01 M
(1.5 K)
18.29 B
1.71 M
N/A
(983)
10.01 M
Day Typical Price
0.0061
0.002
0.03
12.25
0.042
0.005
0.0455
0.45
Accumulation Distribution
0.73
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Market Facilitation Index
0.0083
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
0.0843
0.0
9.2 T
0.0
0.0
9.2 T
0.0
0.0
Period Momentum Indicator
7.0E-4
N/A
0.0195
N/A
N/A
0.001
N/A
N/A
Rate Of Daily Change
1.23
1.0
2.86
1.0
1.0
1.25
1.0
1.0
Day Median Price
0.0073
0.002
0.03
12.25
0.042
0.005
0.0455
0.45
Price Action Indicator
(0)
N/A
0.0098
N/A
N/A
5.0E-4
N/A
N/A
Coefficient Of Variation
1326.37
N/A
520.2
N/A
854.42
1823.82
670.06
813.15
Mean Deviation
15.35
N/A
29.08
N/A
9.72
7.43
19.29
62.39
Jensen Alpha
2.33
N/A
11.26
N/A
3.71
1.03
8.5
32.16
Total Risk Alpha
(2.28)
N/A
2.64
N/A
(1.28)
(1.97)
(0.03)
(6.85)
Sortino Ratio
0.0544
N/A
N/A
N/A
N/A
0.0256
N/A
N/A
Downside Variance
1614.67
N/A
N/A
N/A
N/A
1565.39
N/A
N/A
Standard Deviation
30.65
N/A
62.02
N/A
39.12
20.7
57.95
257.33
Kurtosis
10.01
N/A
20.09
N/A
65.23
21.09
36.23
66.0
Potential Upside
50.0
N/A
84.21
N/A
N/A
25.0
10.89
N/A
Treynor Ratio
(7.68)
N/A
2.1
N/A
0.6086
1.36
7.05
(6.93)
Maximum Drawdown
153.33
N/A
451.8
N/A
330.62
171.75
425.33
2097.0
Variance
939.18
N/A
3846.57
N/A
1530.04
428.67
3358.26
66216.3
Market Risk Adjusted Performance
(7.67)
N/A
2.11
N/A
0.6186
1.37
7.06
(6.92)
Risk Adjusted Performance
0.0674
N/A
0.1568
N/A
0.0992
0.0515
0.1239
0.1039
Skewness
2.14
N/A
4.06
N/A
8.05
2.94
5.85
8.12
Semi Deviation
17.22
N/A
N/A
N/A
N/A
11.47
N/A
N/A
Information Ratio
0.0713
N/A
0.1902
N/A
0.1139
0.0488
0.1471
0.1225
Value At Risk
(33.33)
N/A
(48.53)
N/A
N/A
(13.58)
(10.61)
N/A
Expected Short fall
(48.37)
N/A
N/A
N/A
N/A
(41.99)
N/A
N/A
Downside Deviation
40.18
N/A
N/A
N/A
N/A
39.57
N/A
N/A
Semi Variance
296.66
N/A
N/A
N/A
N/A
131.51
N/A
N/A

AusCann Group Competition Performance Charts

Five steps to successful analysis of AusCann Group Competition

AusCann Group's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by AusCann Group Holdings in relation to its competition. AusCann Group's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of AusCann Group in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact AusCann Group's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to AusCann Group Holdings, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your AusCann Group position

In addition to having AusCann Group in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Chemicals Makers Thematic Idea Now

Chemicals Makers
Chemicals Makers Theme
Companies developing chemicals for crops, soil as well as human, and animals. The Chemicals Makers theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Makers Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in AusCann Pink Sheet

If you are still planning to invest in AusCann Group Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AusCann Group's history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
CEOs Directory
Screen CEOs from public companies around the world
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY